Research Article
Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy
Table 2
Prognostic values of EPHA/EFNA mRNA expression for RFS in different BrCa intrinsic subtypes.
| Subclasses | | HR (95% CI) | |
| EPHA1 | | | | Basal like | 618 | 0.61 (0.48–0.79) | 0.0001 | Luminal A | 1,933 | 0.63 (0.53–0.75) | <0.0001 | Luminal B | 1,149 | 0.63 (0.52–0.76) | <0.0001 | HER2 positive | 251 | 0.55 (0.37–0.8) | 0.0019 | EPHA2 | | | | Basal like | 618 | 0.84 (0.65–1.09) | 0.19 | Luminal A | 1,933 | 0.61 (0.51–0.72) | <0.0001 | Luminal B | 1,149 | 0.76 (0.63–0.93) | 0.0067 | HER2 positive | 251 | 0.669 (0.42-1.03) | 0.068 | EPHA3 | | | | Basal like | 618 | 0.85 (0.65–1.11) | 0.23 | Luminal A | 1,933 | 0.73 (0.61–0.87) | 0.00046 | Luminal B | 1,149 | 1.21 (0.96–1.52) | 0.1 | HER2 positive | 251 | 0.74 (0.5–1.08) | 0.11 | EPHA4 | | | | Basal like | 360 | 0.69 (0.49–0.96) | 0.029 | Luminal A | 841 | 0.69 (0.54–0.88) | 0.0026 | Luminal B | 407 | 0.57 (0.42–0.79) | 0.00047 | HER2 positive | 156 | 0.74 (0.46–1.18) | 0.21 | EPHA5 | | | | Basal like | 360 | 0.45 (0.29–0.68) | 0.00015 | Luminal A | 841 | 0.77 (0.59–1.01) | 0.059 | Luminal B | 407 | 0.66 (0.48–0.89) | 0.0068 | HER2 positive | 156 | 0.74 (0.46–1.19) | 0.21 | EPHA6 | | | | Basal like | 360 | 0.78 (0.53–1.15) | 0.21 | Luminal A | 841 | 1.18 (0.91–1.52) | 0.21 | Luminal B | 407 | 0.61 (0.45–0.85) | 0.0026 | HER2 positive | 156 | 0.53 (0.29–0.94) | 0.028 | EPHA7 | | | | Basal like | 360 | 0.68 (0.49–0.95) | 0.022 | Luminal A | 841 | 1.49 (1.16–1.91) | 0.0016 | Luminal B | 407 | 0.84 (0.61–1.15) | 0.27 | HER2 positive | 156 | 2.32 (1.45–3.72) | 0.00031 | EPHA10 | | | | Basal like | 360 | 0.71 (0.49–1.02) | 0.064 | Luminal A | 841 | 0.54 (0.42–0.7) | <0.0001 | Luminal B | 407 | 0.55 (0.4–0.75) | 0.00012 | HER2 positive | 156 | 1.28 (0.75–2.2) | 0.37 | EFNA1 | | | | Basal like | 618 | 1.36 (1.06–1.76) | 0.016 | Luminal A | 1,933 | 0.89 (0.73–1.07) | 0.21 | Luminal B | 1,149 | 1.38 (1.09–1.75) | 0.0065 | HER2 positive | 251 | 1.45 (0.91–2.33) | 0.12 | EFNA3 | | | | Basal like | 618 | 1.29 (0.97–1.73) | 0.082 | Luminal A | 1,933 | 0.81 (0.68–0.96) | 0.017 | Luminal B | 1,149 | 1.39 (1.1–1.76) | 0.0057 | HER2 positive | 251 | 1.43 (0.96–2.14) | 0.081 | EFNA4 | | | | Basal like | 618 | 1.53 (1.16–2.01) | 0.0022 | Luminal A | 1,933 | 0.72 (0.6–0.86) | 0.00036 | Luminal B | 1,149 | 1.29 (1.05–1.6) | 0.016 | HER2 positive | 251 | 0.82 (0.51–1.3) | 0.39 | EFNA5 | | | | Basal like | 618 | 0.69 (0.54–0.89) | 0.0037 | Luminal A | 1,933 | 0.61 (0.51–0.73) | <0.0001 | Luminal B | 1,149 | 0.67 (0.55–0.83) | 0.00015 | HER2 positive | 251 | 0.66 (0.45–0.97) | 0.033 |
|
|